Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

May 17, 2017May 17, 2017

Spyryx to Present Two Studies on SPX-101’s Ability to Treat Cystic Fibrosis by Clearing Airway Mucus

cystic fibrosis, News

Spyryx Biosciences will present two studies in Washington this week on SPX-101‘s ability to treat cystic fibrosis by clearing mucus from airways. One of the preclinical-trial studies it will discuss ... Read more

April 12, 2017April 12, 2017

Tα1 Molecule Reverses Cystic Fibrosis Tissue Defects in Mice, Study Shows

cystic fibrosis, News

The naturally occurring molecule thymosin α1 (Tα1) reversed tissue defects in mice with cystic fibrosis (CF) and in human cells that contained a mutation associated with the disease, according ... Read more

April 7, 2017April 7, 2017

Spyryx Biosciences Presents Novel Data on CF Therapy SPX-101 at 2 Scientific Meetings

News

Spyryx Biosciences presented new data and updates on its cystic fibrosis (CF) treatment SPX-101 at two recent events: the European Cystic Fibrosis Society Basic Science Conference, which took place March 29-April ... Read more

March 30, 2017March 30, 2017

Stem Cell Therapy May Reduce Lung Inflammation Associated with Cystic Fibrosis

cystic fibrosis, News

Stem cell therapy may reduce lung inflammation in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), according to preliminary results of a pre-clinical-trial study. The findings, presented at ... Read more

March 27, 2017March 27, 2017

Researchers Map 3D Structure of CFTR, the Protein Involved in Cystic Fibrosis

cystic fibrosis, News

Rockefeller University researchers have mapped the three-dimensional structure of the protein involved in cystic fibrosis (CF). The mapping is important because knowing more about the CFTR protein will provide scientists ... Read more

March 23, 2017March 23, 2017

Sound Pharmaceuticals Gets $1.6 Million to Test SPI-1005 as CF Hearing Loss Therapy

cystic fibrosis, News

Sound Pharmaceuticals has received a $1.6 million Cystic Fibrosis Foundation Therapeutics (CFFT) grant to test a therapy it has developed to improve hearing loss in cystic fibrosis (CF) patients being treated with tobramycin. Tobramycin ... Read more

March 15, 2017March 15, 2017

Using Virus May Be Way to Fight Resistant Bacterial Lung Infections, Study Reports

cystic fibrosis, News

Using a virus may be a reliable way to treat antibiotic-resistant bacterial infections in cystic fibrosis (CF) patients’ lungs, according to a study. The approach is called phage therapy. ... Read more

March 6, 2017March 6, 2017

Ataluren Fails to Pass Muster as Treatment for Severe Form of Cystic Fibrosis

cystic fibrosis, News

PTC Therapeutics’ ataluren has failed to significantly improve respiratory function in nonsense mutation cystic fibrosis (nmCF), a severe form of the disease, according to results of a Phase 3 clinical ... Read more

February 27, 2017February 27, 2017

Resunab Shows Potential in Treating Lung Inflammation in Preclinical Study

cystic fibrosis, News

The investigative oral treatment Resunab (JBT-101) shows promise in easing inflammation mediated by immune cells in the lungs of cystic fibrosis (CF) patients, according to results of a preclinical study. Results from a Phase 2 study of ... Read more

February 14, 2017February 14, 2017

Pre-flight Check Can Predict CF Patients’ Need for Supplemental Oxygen on Plane, Study Reports

cystic fibrosis, News

Evaluating patients with cystic fibrosis (CF) before they board a flight may help predict whether they will need supplemental oxygen while in the air to prevent a severe decrease ... Read more